Andreu Vall, Yogesh Sabnis, Jiye Shi, Reiner Class, Sepp Hochreiter, and Günter Klambauer

Drug-induced liver injury (DILI) is a common reason for the withdrawal of a drug from the market. Early assessment of DILI risk is an essential part of drug development, but it is rendered challenging prior to clinical trials by the complex factors that give rise to liver damage. Artificial intelligence (AI) approaches, particularly those building on machine learning, range from random forests to more recent techniques such as deep learning, and provide tools that can analyze chemical compounds and accurately predict some of their properties based purely on their structure. This article reviews existing AI approaches to predicting DILI and elaborates on the challenges that arise from the as yet limited availability of data. Future directions are discussed focusing on rich data modalities, such as 3D spheroids, and the slow but steady increase in drugs annotated with DILI risk labels.

Frontiers in Artificial Intelligence, 4, 2021. doi: 10.3389/frai.2021.638410

Download
View paper
IARAI Authors
Dr Sepp Hochreiter
Research
Health and Well-being
Keywords
Deep Learning, Drug-Induced Liver Injury

©2021 IARAI - INSTITUTE OF ADVANCED RESEARCH IN ARTIFICIAL INTELLIGENCE

Imprint | Privacy Policy

Stay in the know with developments at IARAI

We can let you know if there’s any

updates from the Institute.
You can later also tailor your news feed to specific research areas or keywords (Privacy)
Loading

Log in with your credentials

Forgot your details?

Create Account